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This special issue introduces the emerging contours of a series of large-scale biological research 
projects, drawing them together in dialogue with each other and in critical debate with the extant 
rhetorics and practices of ‘big science’ in biology. The category of ‘big biology’ is in question 
from the start. On the one hand, it serves to frame and align the ways in which these projects are 
being developed and positioned in relation to epistemic ambitions, funding imperatives, research 
governance, choice and maintenance of infrastructure, geographical scope and social importance, 
especially within scientific, media and policy narratives. Given the vast amounts of resources 
(skills, technologies, funding and manpower) directed to contemporary bioscience research, and 
the growing emphasis in Europe, the USA and elsewhere on funding co-ordinated initiatives and 
projects, the suggestion that biology is ‘big science’ increasingly figures in popular 
characterisations and science policy statements (see for example Weinberg, 1999; Collins et al, 
2003; Nass and Stillman, 2003; Esparza and Yamada, 2007; see also Vermeulen, 2010). On the 
other hand, the idea and operation of an emerging ‘big biology’ is far from singular and 
unproblematic, especially given the difficulties in defining what counts as a shift in the scale of 
research. The range of initiatives covered in this volume immediately attests to its diverse 
characteristics, and points to further difficulties in attempting to define what is meant by ‘big 
biology’ today, and how it differs, if at all, from historical manifestations of large-scale science. 
We thus suggest these claims deserve careful scrutiny within science and technology studies 
(STS) and in relation to changing histories and geographies of science. The authors of this 
collection draw on a variety of empirical studies to consider how this reorganisation of research 
and achievement of scale is linked to changes in the production, flow and valuation of knowledge 
in the contemporary biosciences. In this introduction, we build from these case studies to explore 
the definitional, scalar and spatial issues at play in such large-scale research, and reflect on the 
scientific and social stakes of these forms of ‘big biology’. 
 
Our starting point is recognition of the need to integrate arguments from literatures on ‘big 
biology’ and infrastructure in STS with scholarship on the geographies of science. Given the 
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centrality of ideas about size, complexity and international collaboration associated with ‘big 
biology’ in STS (e.g. Parker et al, 2010), there has been surprisingly little exploration of its 
scalar, spatial and geographical dimensions to date. This is a notable absence given the rich 
literature on historical geographies of science, which explore the social and material 
characteristics of sites privileged for the production of scientific knowledge and the influence of 
local characteristics on how knowledge is created and received (Schaffer, 1998; Livingstone, 
1995, 2003; Powell, 2007); and more recent work emphasising the flows of knowledge and the 
practices mobilising scientific data and materials across space, which brings social relations of 
trust, the formation of scientific standards and infrastructures, and the commodification of 
materials and practices to the fore (Latour, 1987; Naylor, 2005; Secord, 2004; Parry, 2004; 
Howlett and Morgan, 2010). As illustrated by the case studies in this volume, the proliferating 
circulations of materials, models and data produced through contemporary ‘big biology’ lead to 
conceptual and practical challenges in defining, managing and aligning spatial and temporal 
scales in life science research. New questions are emerging about how these configurations are to 
be bounded, how they are co-ordinated, and the extent to which they might mesh with or work 
against the temporalities and spatialities of the biological processes they are seeking to study. 
 
The endeavours examining ‘big biology’ in this special issue range from self-identified ‘projects’, 
such as the Human Genome Project (Hilgartner) and the Knock-Out Mouse Project or KOMP 
(Davies), to the digital infrastructures designed to manage the challenges of big-data in model 
organism or cancer research (Leonelli), and the large-scale ambitions of new disciplinary areas 
like synthetic biology (Frow), and systems biology (Calvert). What holds them together is the 
suggestion that, in both in rhetoric and practice, certain biological research practices are being co-
ordinated to understand and manage biological complexity for specific goals, whether defined by 
research communities or in relation to wider social imperatives. In each of these cases, these 
developments are underpinned by the expectation that expanding the scale and speed of 
biological enquiry will improve the value of biological research1. In their different configurations, 
these projects all demonstrate the emergence of initiatives involving large numbers of people, 
resources and materials directed towards prescribed goals, with the anticipation that speed, 
whether measured through outputs or research milestones, is an effective assurance of research 
quality and efficiency. There are normative assumptions that bigger will be faster, and that faster 
                                                
1 As the commentary by Lezaun points out, there is a double act of value creation and destruction in these 
collaborative practices. Devaluation is an equally significant process if researchers are to be encouraged to 
share resources previously held by individual laboratories or institutions.  
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is better. We thus suggest these large-scale initiatives are an inventive re-organisation of the 
spatiotemporal dynamics governing biological research, which has epistemic, spatial and social 
implications for the knowledge being produced and for the researchers and experimental subjects 
(whether human or non-human) included in their scope. Bringing these case studies together 
allows exploration of why and how this reorganisation of biological research is emerging: 
through new forms of governance (Hilgartner), spatial imaginaries (Davies), research 
infrastructures (Leonelli) and articulations of value (Calvert), and by creating new kinds of moral 
economies in biology (Frow). Such moral economies define both the inside and the outside of 
research, facilitating the identification of those and that which is excluded. Looking 
comparatively across these case studies facilitates analysis of the tensions within and gaps 
between aspirations, the geographical and biological boundaries that are being set, and the related 
shifts in how biological phenomena are being apprehended. 
 
Geographical scholarship has pointed to the importance of critically examining the multiple 
registers of scale at play in key concepts such as maps, models, complex systems and the social 
constitution of space, which are being reshaped in the practices of ‘big biology’.2 Scalar 
considerations are central to the organisation of research in ‘big biology’, the very objects of 
interest (organisms), and the content of the knowledge produced about them. Three aspects in 
particular come to the fore. First, there is the centrality of scale to the mapping and modelling 
aspirations of these different projects in ‘big biology’; each case study offers a slightly different 
resolution to the answer ‘what is a biological object?’ which do not necessarily articulate easily. 
Second, different scales of accountability are critical to the management practices associated with 
these projects, and particularly to the institutionalisation of new forms of standardisation, 
evaluation and economisation that are implemented to try and realise the potential from 
economies of scale for scientific communities, national investments and biological knowledge 
production. And third, the scalar discourses of ‘big biology’, which stress the global and large-
scale, require critical reflection, for such discourses risk obscuring the multiplicity of scientific 
and material practices, the divergent places and communities, and the contested spatial 
imaginaries now involved in making up ‘big science’. Some of these processes suggest, and in 
some cases reinforce, hierarchical scales – as in the definition of global standards from local sites; 
                                                
2 For a critical discussion and review of the concept of scale in geography see Marston et al (2005), Leitner 
and Miller (2006), and Moore (2008). The relations between scale, size and different orders of complexity 
have also been a focus of work in STS; see for example Law (2004) and Kwa (2002). A recent 
interdisciplinary workshop on Scalography in 2009 bought together scholars in STS, geography and other 
disciplines to explore the potential of turning the problem of scale into an object of productive enquiry. See 
http://www.sbs.ox.ac.uk/research/sts/research/Pages/scalography.aspx <last accessed 24/09/13>.  
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others are more horizontally networked – as in the more distributed processes of collecting and 
curating data. We do not suggest that these biological, managerial or geographical scales pre-exist 
current developments in the organisation and practice of biological research; the forms of large-
scale science that emerge from these intersections are precarious achievements and could easily 
be disrupted by future shifts in the scientific, geopolitical and economic contexts of research. 
However, we do suggest that there is a politics of scale requiring empirical analysis, for to change 
scale, even if only discursively, is to intervene in the distribution of levels of decision-making, 
power and control (Bulkeley, 2005).  
 
The diversity of scalar claims and temporal-spatial configurations in the idea of ‘big biology’ is 
detailed in Calvert’s paper, but some significant contours across the papers are worth mapping 
out here. There is the attempt to use large-scale infrastructure projects to reshape biological 
research practices, which can themselves be either centralised (e.g. KOMP) or more networked 
(e.g. parts-based synthetic biology). There is the growing international scope of scientific 
collaborations, with ‘big biology’ implicated in emerging patterns in the globalisation of science, 
where the mobilities of data, people and practices both build on and potentially decentre earlier 
geographies of knowledge.3 Further, the social imaginaries underlying ‘big biology’ are 
becoming more expansive, taking biological goals closer towards societal needs, or grand 
challenges, whether in systems biology (Calvert), translational research (O’Malley and Stotz, 
2011; Davies, 2012) or one-health medicine (Cassidy and Woods, 2012). On the temporal level, 
there are new imperatives for working faster and more efficiently with the ‘deluge of data’ from 
sequencing technologies (Leonelli, 2010a), and demands for short-term returns on translational 
medicine and research impact (Sunder Rajan and Leonelli, 2013). Last, but by no means least, 
there is ‘big money’ at stake, for the idea of a ‘big biology’ promises to realise the value of large 
investments through economies of scale, reallocating funds across different research practices, 
remaking forms of bio-value, and redistributing roles and rewards within the sciences. Thus 
despite, or perhaps because of, its discursive imprecision, the continuing use of the term ‘big 
biology’ demands critical attention and empirical exploration as an inventive way of defining and 
organising biological research.  
 
                                                
3 There are now a large number of global and regional studies of science and innovation outside of Europe 
and the USA, most notably in China, India and Brazil (see for example, Sunder Rajan, 2006; Salter et al, 
2009). These explore the situated nature of knowledge production in modern value-knowledge-networks 
that are increasingly globalized, even whilst distribution of therapeutic and other benefits of the biosciences 
remains uneven. 
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The historical lineages of these claims are also important, for the growing emphasis on ‘big 
biology’ is often identified in relation to the legacies of biology’s own history, notably the Human 
Genome Project (HGP), but also in relation to other scientific trajectories, such as the post-war 
emphasis on ‘big physics’ (see Kevles, 1997). As Hilgartner’s paper explores, the constitution of 
the HGP as a project, with identified milestones over time and across space, set up a template and 
a series of expectations for both the organisation and the evaluation of large-scale bioscience. 
This was not the first time the history of the life sciences witnessed an attempt to assemble vast 
amounts of resources, funding, individual skills, expertises and data productively; think only of 
Linnaeus’ 18th century botanical networks (Mueller-Wille, 2004) or the International Biological 
Programme, running from 1964-1974 (Aronova et al, 2010). The vision underlying the HGP is 
also rooted in 20th-century precedents for the organisation of research around non-human model 
organisms such as Drosophila (Leonelli and Ankeny, 2012). We focus on the HGP here because 
it has come to epitomise a specific template for what counts as a big biological project today, 
involving (1) the ideation of an epistemic project in biology of value to state funders, and (2) its 
institutionalisation through the top-down but distributed governance of several competing centres 
across geographical locations.  
 
With this framework, project management became a central organisational tool for directing the 
spatio-temporal dynamics and scales of the HGP. The co-ordination of efforts, the evaluation of 
success, and the demonstration of accountability were achieved by focusing on measurable 
milestones, or landmarks, through the production of sequence-tagged sites at each genome centre. 
Focusing on sequence data as the main result of experimental efforts meant each participating 
institution could contribute to the overarching effort with the same ‘currency’, with little regard 
for qualitative differences in the ways in which each centre produced their data. This in turn 
meant research was turned into a matter of incremental production, aimed at the aggregation of 
commensurable and quantifiable masses of data across space, where speed was the main factor in 
evaluating the success of contributions by each centre. Thereby, speed in data production and 
dissemination was placed at the centre of the HGP; centres were expected to compete to improve 
their rates of sequence production. Failure became a matter of managerial logics, defined by 
assessing the relative performance of centres involved in this ‘data race’. If centres did not keep 
up, they did not get further funding. At the heart of the HGP was thus the mobilisation of a 
particular conceptualisation of informationalised biology, linked to the transportability, 
accumulation and acceleration of data-collection procedures. The apparent success of this 
targeted, centralised and quantifiable way of doing biology has brought increased funding, from 
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the NIH and elsewhere, to subsequent large-scale infrastructure projects, introducing what has 
been identified as a post-Fordist shift in the biosciences (Gaudilliere and Lowy, 1998; Bonneuil 
and Thomas, 2009). But as Hilgartner reports, what kind of endeavour should follow on from this 
way of conceiving a ‘biological project’ was not conceptually obvious. In part this is due to the 
recognition of growing complexity and relationality in post-genomic approaches, which are 
arguably harder to capture through the incremental accumulation of data, experiments and 
models, and in part because of the logistical difficulties in sustaining and advancing research 
through such a top-down approach. 
 
Comparison with earlier academic analyses of ‘big science’ in the form of physics programmes is 
also instructive, for it highlights further ambiguities around the notions of scale at work in 
contemporary ‘big biology’. Social scientific accounts of these earlier instantiations of large-scale 
science often focus on the expensive equipment and centralised facilities of 20th century physics 
(e.g. Weinberg, 1967; Hughes, 2002; Galison, 1997; Traweek, 1988), where the large numbers of 
people working on projects based around large apparatus function as a visible marker of ‘big 
science’. Particle physics in particular has a long history of orchestrated efforts to generate large 
quantities of data through centralized experimental set-ups, such as the hadron collider. This 
phenomenon has been well-documented in the case of CERN (Kriege, 1996; Knorr-Cetina, 
1999). The practices of ‘big physics’ were dependent on an international migratory workforce, 
shaped by global governance, and explicitly geopolitical in ambition. Scale emerges from these 
experimental sites by way of their articulation with national funding priorities and international 
scientific collaborations. They also depended on the enrolment and integration of very specific 
sets of experts. Such experts are not easy to integrate, as Galison (1997) and Knorr-Cetina (1999) 
demonstrate in their discussion of the interactions between theoreticians and experimentalists. But 
their respective responsibilities are relatively well-defined and they were generally visible to each 
other. In comparison, contemporary large-scale biology does not function through a single 
experimental site, but operates through the bureaucratic surveillance of widely distributed and 
less visible research practices, to include a variety of differently situated forms of expertise. The 
labours of ‘big biology’ involve an increasing raft of fieldworkers, the scale of whose 
contributions are not always discernible to others. The relevant skills and knowledge to tackle 
problems may also come from any field of the sciences or even the humanities, as demonstrated 
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by the unexpected collaboration between biologists, medics, computer scientists and logicians 
involved in setting up classification systems for bio-medical databases (Leonelli 2010b).4  
 
One reason for the fluid mix of skills and scale in large-scale biology projects is the living and 
lively nature of biological objects. A major task for the life sciences is finding ways to manage 
the irreducible contingency and emergent properties of organisms, through strategies to reduce 
and parcel complexity into manageable units, for instance through the use of model organisms 
and other disciplinary lenses. Yet, and as often pointed out by biologists themselves, this requires 
constant awareness of the limitations of any one perspective and the willingness to accept that 
new strategies, ideas and skills might be needed to tackle emerging questions. Scale has long 
been a key criterion for reduction and for the division of research labour, for instance enabling 
biologists to distinguish between molecular and cellular levels, or between microbial and 
macrobial scales of analysis (Dupré, 2011). In contemporary large-scale biology, the managerial 
obsession with the ‘project’ as the basic unit for research organisation acts as a further device to 
direct and limit the attention of researchers, preventing individual laboratories from ‘drifting off’ 
when they encounter something interesting or unexpected. However, any such attempt to 
compartmentalise and standardise biological processes is necessarily bound to specific short-term 
research goals. The tensions that emerge between attempts to govern and regulate interactions and 
divisions of labour between the components of large projects, and the importance of letting 
individual laboratories explore biological systems in creative and unpredictable ways, are another 
important characteristic of contemporary ‘big science’, one that is discussed and problematised in 
most of the papers in this special issue.  
 
Rhetorics and practices of data sharing, standardisation and milestone-setting mobilise and 
aggregate biological properties and capacities at different scales, through different means and 
with different effects. Some of these projects may be bigger and faster than what came before, but 
the question of whether they are necessarily better is more openly contested. Such questioning is 
coming from at least three different directions, which we explore in turn. The first is in the 
encounter between engineering or managerial logics and experimental biological emergence. The 
second is in the relation between global and local practices in specific experimental settings and 
                                                
4 We are not in a position to address potential parallels between contemporary developments in biology and 
physics, owing to the relatively scarce literature available on large-scale physics today. Forthcoming 
publications by Sharon Traweek and collaborators will undoubtedly facilitate comparison. 
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individual locales. The third is from the opening out of the ambitions of ‘big biology’ to a wider 
set of societal needs, and their transformation into grand challenges.  
 
In relation to the first, the technical and biological logics of investing so heavily in high-
throughput techniques may be reaching their limits. This critique was articulated in relation to the 
HGP, where investments in sequencing came into conflict with norms of discovery-driven 
science (e.g. Balmer, 1996), and it is now re-emerging with new strength. New bottlenecks are 
evident in the co-ordination of large-scale projects that cannot be solved solely by working faster 
within existing disciplinary areas. Questions about complex biological phenomena such as 
metabolism or specific behavioural traits require the integration of results from several branches 
of biology (Landecker forthcoming).5 The relationship between standardization and innovation or 
biological insight is being repeatedly questioned in relation to large-scale biology. Leonelli and 
Davies both discuss the challenges in prioritising and aggregating standardised data when faced 
with the enormous complexity of the biological systems under investigation, the parameters of 
which are potentially infinite. Similarly, Frow shows how attempts to standardize biological 
components to enable the industrial scaling-up of related biotechnologies (as in the case of 
Biobricks in synthetic biology) is encountering multiple forms of local resistance, as the 
contextual and contingent qualities of biological complexity and experimental practice (and 
practitioners) challenge and re-define the contours of this imagined design space. Calvert 
discusses the contrast between synthetic biologists, many of whom view the management and 
containment of context and complexity as a key organizing principle for their activities, and 
systems biologists, who embrace biological complexity and emergence. The emphasis on an 
integrative systemic approach as the central rationale of systems biology means it tellingly falls 
furthest away from easy identification as ‘big biology’ (see also O’Malley and Dupré, 2005). 
Ideas about context, control, reductionism and integration are granted different epistemic value 
across these two branches of ‘new biology’, and help to constitute in distinct ways their practices, 
institutional configurations, collaborative strategies, and rhetorical self-presentations in broader 
social and policy contexts.  
 
The second set of questions emerges at the interface between the global biological and the locally 
contextual. Such questions were present in the HGP — where a key organizational question was 
‘What does it mean to run a genome centre here?’ (Hilgartner) — and have not gone away. As 
                                                
5 There is also growing demand for databases capable of integrating research across diverse research 
areas, focusing on different organisms, levels of organisation and types of data. 
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Leonelli illustrates, large-scale infrastructure projects would have no value if local research 
groups were not using them to tackle specific questions in the context of their own laboratory set-
up and species of interest. While the emphasis of large-scale sequencing projects at the turn of the 
century was on disseminating data as widely as possible, 21st century biology has turned 
decidedly to the question of how specific laboratories can actually integrate and re-use the data 
available online for their own research purposes. Similarly, Davies highlights key debates within 
the mouse genetics community over whether the most valuable biological insights are likely to 
emerge through centrally engineered programmes or in the context of smaller research projects 
and ‘letting nature tell us […] on an ad hoc, case-by-case basis’. Arguably there is no ‘global’ 
biology, as all biological claims are situated within specific research settings and with reference 
to specific forms of life. What counts as synthesis, unification or integration of biological claims 
varies, depending on the purpose and means of aggregation at hand.6  
 
The increasing demand for data integration and collaboration among scientists also has the 
potential to bring some knowledge communities into closer dialogue and interaction. This is 
illustrated in a number of the papers, such as in Leonelli’s work on different kinds of databases 
and Davies’ research exploring the integration of previously dispersed scientific communities 
working with mouse models. Yet, as shown Leonelli, and others, the development of ‘big 
biology’ also increases entry costs, and is accompanied by continuing debates about the 
ownership of and access to data, as well as arguments about the spatial location of databases and 
other resources, resulting in new forms of exclusion and enclosure. ‘Big biology’ is not only 
characterised by accelerating spatial and temporal flows of biological throughput, it is also 
patterned by the spatial, political and economic redistribution of resources across disciplines, 
researchers and countries, whether seeking to build capacity within the European ‘knowledge-
based bio-economy’ or to increase efficiencies through out-sourcing mundane work. It thus 
becomes important to highlight the counterpart to the question asked above with reference to the 
HGP: ‘What does it mean not to run a genome centre there?’ and to interrogate who, in the 
context of these asymmetric collaborations, gets to define where is ‘here’ and ‘there’. As Sunder 
Rajan’s commentary points out, the relations between the global and the local in the production of 
biological knowledge intersect in critically important ways with questions of the transnational and 
postcolonial (see also Anderson, 2009; Harding, 2011).  
                                                
6 Philosophers of biology have reflected extensively on what it means for biological claims to be 
aggregated, and how one can think about unification and ‘theory’ in biology (see e.g. the Biological Theory 
special issue on ‘The Meaning of Theory in Biology’ edited by Callebaut et al (2013)). 
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Finally, we turn to closing questions about whether these spatial complexities and epistemic 
controversies signal the end of the aspirations of ‘big biology’, or their transformation into 
something different, and to the roles social scientists are playing in shaping these changes. In her 
paper on systems biology, Calvert identifies the reshaping of the practices of large-scale science 
towards socially defined goals in the form of ‘grand challenges’. This brings social questions, and 
sometimes social science researchers, into the explicit framing and evaluation of large-scale 
biological research, albeit in different ways. Constructing challenges for science at a global scale 
can provide a social rationale for research, and promises to encourage the social engagement and 
strategic positioning of researchers and their funders. At the same time, it risks reinforcing the 
accelerating logics of ‘big biology’ through the ethical injunction to act as soon as possible in the 
face of emerging threats to the environment and global health. Moreover, the identification of 
grand challenges in this way may import culturally specific notions of the global, ideas of health 
and ontologies of life into the definition of research priorities, resulting in the exclusion of other 
useful trajectories (Hulme, 2010). There are thus a series of questions about the roles social 
scientists can or should play vis-à-vis these new collaborative practices, the extent to which they 
are able to open up spaces for constructive critique, and the ways in which they may be folded 
into these existing dynamics and further perform these spatial and temporal dynamics of 
accountability.  
 
The cases examined in these papers do call into question whether such grand challenges always 
encourage biologists to engage with the social outcomes of their research. Patterns of wider social 
engagement are unevenly distributed across the initiatives in this volume, with divergent 
understandings or imaginations of the public and regulatory dimensions of research, and differing 
degrees of engagement with social scientists. For instance, while the HGP and synthetic biology 
have incorporated explicit ELSI dimensions and have encouraged interactions between natural 
and social scientists, this form of interdisciplinary exchange is almost entirely absent from 
KOMP, systems biology and the set-up of data sharing tools. Why this should be the case 
becomes a socially, politically and spatially intriguing set of questions to ask, particularly since 
many of the authors in this collection have conducted their empirical research by entering 
collaborative relationships with the scientists and funders of the initiatives they study. The study 
of the practices of ‘big biology’ unavoidably includes some form of incorporation and personal 
investment into those practices, ranging from friendly relations with researchers, which guarantee 
long-term dialogue and access to laboratories (Davies, Hilgartner), to the involvement in 
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synthetic biology projects as collaborators or as ‘ELSI consultants’ (Frow, Calvert), and the 
appointment to steering committees for the coordination of research efforts (Leonelli). Even when 
social dimensions of the research are explicitly sought, for example by incorporating social 
scientists into the scope of research endeavours such as nanotechnology and synthetic biology, 
social researchers themselves can occupy a peculiar position, also serving as representatives of 
the public and proxies for scientific accountability to public funding and society at large 
(Doubleday, 2007; Calvert and Martin, 2009). Lezaun elaborates on these questions and their 
implications in his closing commentary, brining the papers into dialogue with critical literatures 
on the growth of the project as an organisational form in contemporary capitalism. 
 
In conclusion, ‘big biology’ is a quite contested and explicitly divisive term, for to recognise 
something as large-scale research by definition identifies other science as ‘small’. As Hilgartner’s 
opening paper explains, the HGP was constituted alongside the simultaneous redefinition of 
extant molecular biology as ‘ordinary biology’. This served the purpose of positioning the HGP 
as being about resources, rather than a competitor for research funds. Yet, this special issue shows 
that as ideas and models of large-scale science proliferate and diversify, more people and more 
projects are being drawn into their scope and the spatial, social and epistemic divisions of labour 
that they create. The contestations and concerns about ‘big biology’ continue, both within the 
community and from its diminishing outside7.  However, as it grows and diversifies, large-scale 
bioscience retains these expansionary logics, through forms of accounting that value acceleration 
and efficiency, and incorporate the social injunction that ‘something must be done’. As more and 
more biological research is brought within the auspices of ‘big biology’, whether as explicit 
projects or more expansive grand challenges, there is less and less scope to be left outside its 
logics and reach, for scientists and perhaps for social scientists too.  
                                                
7 There are growing concerns about who might be left ‘outside’ of these research projects and thus be in a 
position to review them from what scientists would deem an objective position (Xin and Yidong, 2006).  
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